Terveystalo Oyj - Other information disclosed according to the rules of the Exchange

Exercise of over-allotment option in relation to the IPO of Terveystalo Plc and termination of the stabilization period

TERVEYSTALO PLC STOCK EXCHANGE RELEASE 30 October, 2017 at 19:00 EET

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE
REGION OF THE PEOPLE'S REPUBLIC OF CHINA, JAPAN, SOUTH AFRICA OR THE UNITED
STATES, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR
DISTRIBUTION WOULD BE UNLAWFUL.

Exercise of over-allotment option in relation to the IPO of Terveystalo Plc and
termination of the stabilization period

Terveystalo Plc ("Terveystalo" or the "Company") has received a notification
that Skandinaviska Enskilda Banken AB (publ) Helsinki Branch ("SEB"), the
stabilizing manager in the initial public offering of Terveystalo (the
"Offering"), has today decided to fully exercise the over-allotment option
granted by Lotta Holding I S.à r.l. ("EQT"). SEB will purchase 11,713,918 shares
in the Company from EQT in accordance with the over-allotment option agreed in
connection with the Offering at the subscription price of the Offering of EUR
9.76 per share. The number of shares to be purchased equals the amount of shares
that SEB has borrowed from EQT to cover over-allotments. The ownership of EQT in
the Company after exercising the over-allotment option will be 14,510,320
shares, representing 11.33 percent of all shares in the Company.

No stabilization measures have been carried out since the listing and as a
result of the share price development SEB has decided to terminate the
stabilization period.

Terveystalo Plc
Communications

Further enquiries:
Kati Kaksonen, Director, Investor Relations & Finance Communications,
Terveystalo
Tel. +358 (50) 3931561
kati.kaksonen@terveystalo.com

Distribution:
Nasdaq Helsinki Ltd
Principal media
www.terveystalo.com

Terveystalo in brief
Terveystalo is a leading private healthcare service provider in Finland offering
primary and outpatient secondary healthcare services to corporate, private and
public sector customers. The Company's healthcare service offering includes
general practice and specialist medical care, diagnostic services, outpatient
surgery, dental services and other adjacent services, which comprise its
integrated healthcare care chain. The Company also offers a suite of digital
healthcare services. Terveystalo is able to provide nationwide reach through its
approximately 180 clinics, covering all 20 of Finland's largest cities, together
with its digital platforms.

Terveystalo's operations are driven by its scale and supported by centralized
functions and standardized operating practices. At the core of Terveystalo's
strategy is a focus on providing medical quality and positive customer
experiences, maintaining a competent and satisfied base of healthcare
professionals and developing a variety of customized digital tools.

In 2016, the Company had approximately 1.0 million individual customers as well
as approximately 2.7 million doctor visits, accounting for 12 percent of the
total doctor visits in Finland. The Company's customers are divided into three
groups: corporate customers, who the Company partners with to provide, for
example, occupational healthcare services to their employees, private customers
and public customers, who the Company partners with to provide public healthcare
services and occupational healthcare services to municipal employees.
Terveystalo had approximately 4,445 employees (including part-time employees)
and approximately 4,400 private practitioners as at June 30, 2017.

DISCLAIMER
This announcement does not constitute an offer for sale of, or a solicitation of
an offer to purchase or subscribe for, any securities in the United States.
Securities may not be offered or sold in the United States unless they are
registered or are exempt from registration under the U.S. Securities Act of
1933, as amended. The information contained in this announcement is for
informational purposes only and does not purport to be full or complete.
Terveystalo does not intend to register any offering in the United States or to
conduct a public offering in the United States. Copies of this announcement are
not being, and should not be, distributed in or sent into the United States.
It may be unlawful to distribute this announcement in certain jurisdictions.
This announcement is not for distribution in Australia, Canada, the Hong Kong
special administrative region of the People's Republic of China, Japan, South
Africa, the United States or to any other jurisdiction where such distribution
would be unlawful. The information in this announcement does not constitute an
offer of securities for sale in such jurisdictions.
In the United Kingdom, this announcement is for distribution only to and is
directed only at persons who (i) have professional experience in matters
relating to investments which fall within Article 19(5) of the Financial
Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the
"Financial Promotion Order"), (ii) are persons falling within Article 49(2)(a)
to (d) ("high net worth companies, unincorporated associations etc.") of the
Financial Promotion Order, or (iii) are persons to whom an invitation or
inducement to engage in investment activity (within the meaning of section 21 of
the Financial Services and Markets Act 2000) in connection with the issue or
sale of any securities may otherwise lawfully be communicated or caused to be
communicated (all such persons together being referred to as "Relevant
Persons"). This announcement is directed only at Relevant Persons and must not
be acted on or relied on by persons who are not Relevant Persons. Any investment
or investment activity to which this announcement relates is available only to
Relevant Persons and will be engaged in only with Relevant Persons.
This announcement has been prepared on the basis that any offer of securities in
any Member State of the European Economic Area, other than Finland and Sweden,
which has implemented the Prospectus Directive (2003/71/EC, as amended,
including by Directive 2010/73/EU, the "Prospectus Directive") (each, a
"Relevant Member State") is made pursuant to an exemption under the Prospectus
Directive, as implemented in that Relevant Member State, from the requirement to
publish a prospectus for offers of securities. Accordingly the securities may
only be offered in Relevant Member States (a) to any legal entity which is a
qualified investor as defined in the Prospectus Directive; or (b) in any other
circumstances falling within Article 3(2) of the Prospectus Directive.
This announcement does not constitute or form part of any offer or invitation to
sell or issue, or any solicitation of any offer to purchase or subscribe for any
shares or any other securities nor shall it (or any part of it) or the fact of
its distribution, form the basis of, or be relied on in connection with, any
contract therefor. The information in this announcement is subject to change.

[]